D-399-2014 Class III Terminated

Recalled by Mutual Pharmaceutical Company, Inc. — Philadelphia, PA

Recall Details

Product Type
Drugs
Report Date
January 15, 2014
Initiation Date
February 27, 2013
Termination Date
April 1, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Fenofibric Acid, immediate release tablet, 35 mg, 30 count bottle Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA NDC 53489-677-07

Reason for Recall

Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated." The labeling for the recalled lots

Distribution Pattern

Nationwide and Puerto Rico.

Code Information

Lot 6561703, exp. 03/14